Plain-English translation of NCT07185971 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing the PAVE (Parallactic Visual-Field Enhancement) System, a virtual reality headset therapy designed to help restore lost vision in people who have experienced a stroke, traumatic brain injury, or brain surgery. The system displays special visual training exercises on a headset that you wear for 30-minute sessions. Researchers want to see if this treatment can help improve the area of vision that was damaged by the brain injury.
When a stroke, brain injury, or surgery damages the brain's visual centers, it can cause permanent loss of part of the visual field โ meaning people lose the ability to see in certain areas, even though their eyes themselves are healthy. There are very few treatments available for this type of vision loss, and this trial is testing whether specialized virtual reality training might help the brain recover or adapt to restore some of that lost sight.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you qualify, you will visit a clinic at least once per week for 8 weeks. At each visit, you will wear a virtual reality headset for about 30 minutes and complete visual training exercises displayed on the screen. Researchers will test your vision before and after the treatment period using standard eye exams, and they will also ask you to answer questions about how your vision and daily functioning have changed. The entire study takes about 8 weeks from start to finish.
AI-generated summary from trial data ยท Aug 6, 2026 ยท Not medical advice
United States